Cardiac Ablation Technologies Market
Cardiac Ablation Technologies Market Analysis by Technology (Radiofrequency, Ultrasound, Cryoablation, Microwave, Laser Cardiac Ablation Technology), by Application (Atrial Fibrillation, Ventricular Tachycardia), by Region – Global Forecast 2022-2032
Analysis of Cardiac Ablation Technologies market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiac Ablation Technologies Market Outlook (2022-2032)
The cardiac ablation technologies market is forecast to reach US$ 4,919.35 Mn in 2022, up from US$ 4,427.89 Mn in 2021, representing a Y-o-Y increase of 11.1%.
| Attributes | Details |
|
Market Size (2022) |
US$ 4,919.35 Mn |
|
Projected Market Value in 2032 |
US$ 15,007.95 Mn |
|
Value CAGR (2022-2032) |
11.8% |
|
Market Share of North America |
37% |
|
Revenue Contribution of APAC |
40% |
|
Key Companies Profiled |
|
A surge in atrial fibrillation cases is proving to be a growth generator as cardiac ablation technology is prominently used for its treatment. Revenue across the radiofrequency segment is expected to gather considerable momentum, anticipated to account for over 50% of global revenue.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue from Cardiac Ablation Technologies Industry from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
Historically, the demand for cardiac ablation technologies witnessed stellar growth, expanding at a CAGR of 11.1%. This market growth was driven by the introduction of next-generation ablation devices, as well as the widespread use of minimally invasive techniques.
According to the latest analytical report, the global cardiac ablation technologies market is projected to expand at a CAGR of 11.8% during the forecast period from 2022 to 2032. The global cardiac ablation technologies market is anticipated to be driven by the high prevalence of cardiac diseases, improvements in the health care sector, and an upsurge in focus on research and development. Considering these factors, the market worth is estimated to surpass US$ 15 Bn by the end of 2032.
What are the Factors Driving the Demand for the Cardiac Ablation Technologies?
Rising acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market.
Along with this, the mounting rate of the geriatric population in countries the U.S., most countries of Western Europe, and Japan is increasing the incidence of cardiac diseases. This is attributed to enhanced health care infrastructure, favourable reimbursement policies, and advancements in health care facilities in these countries. Moreover, access to various diagnostic and treatment services has improved in recent years, especially in developed countries.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Key Market Trends & Growth Opportunities in Cardiac Ablation Technologies?
The introduction of hybrid surgical-catheter ablation helps electrophysiologists in executing heart surgeries with nominal invasion, thus reassuring patients to undergo surgeries. The adoption of robotic technologies is intended at proposing augmented safety and accuracy to the cardiac ablation procedure. For instance, advancements like balloon-mounted technologies, multi-electrode ablation catheters, and other similar developments are functioning as a boon for the growth of the cardiac ablation technology market.
Moreover, owing to a shift in the trend of patients demanding shorter hospital stays and negligible post-surgical cramps to recover as soon as possible, this segment is experiencing tremendous growth opportunities in developed countries. This has encouraged manufacturers to make consistent efforts towards utilising advanced technology to reach the internal organs through small incisions, and relatively low blood loss to achieve better recovery time.
Country-wise insights:
Why North America Remains at the Forefront of Cardiac Ablation Technologies?
Rising Prevalence of Cardiac Ailments and Effective Product Positioning Spurring Expansion
North America is expected to capture 37% share of the global cardiac ablation technologies market, as it consists of leading players-Johnson & Johnson, Abbott, and Boston Scientific Corporation. The easy accessibility of state-of-the-art and cutting-edge technology underpins the developmental efforts of these players, which helps them in establishing a diversified product portfolio.
Effective product positioning and advancements in technology help these players in generating revenue from other regions. For instance, Broward Health Medical Centre is establishing a robotic electrophysiology (EP) program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida.
Besides efforts put in by these leading players, demand for cardiac ablation systems is substantially high in the U.S due to a huge number of patients suffering from heart conditions. Numerous studies have found that cardiac arrest is the leading cause of death in the U.S. This makes the country a key cardiac ablation technologies market, which, in turn, is attributing a pole position to North America.
How is Asia Pacific Performing in the Cardiac Ablation Technologies Industry?
Inexpensive Manufacturing Costs Encouraging Companies to Invest in the Region
Asia Pacific is anticipated to cultivate at a rapid pace throughout the forecast period, due to ever-increasing cases of atrial fibrillation and an upsurge in health care expenditure across the region. Substantial investments from prominent players in the region owing to cheaper manufacturing in India and China will further assist in escalating the growth rate of the cardiac ablation technology market.
The region offered significant growth prospects for the ablation technology market. Backed by the swelling incidence and prevalence of cancer and cardiac conditions, technological advancement in ablation products and technology, the market is likely to prosper during the forecast period, accumulating a market share of almost 40% through 2032.
Category-wise insights:
Why Radiofrequency is Most Preferred in Overall Cardiac Ablation Technologies?
Higher Degree of Safety and Short Procedure Duration
Adoption of radiofrequency is expected to add a significant revenue share of around 55% to the cardiac ablation technologies market by 2032, while laser technology would witness the highest adoption rate, considering its high precision rate and superior outcomes.
Owing to the lower cost of radiofrequency ablation procedures compared to other ablation techniques, combined with their higher safety, efficacy, and short procedure duration for the treatment of cancer, atrial fibrillation, and pain management, the radiofrequency ablation section is projected to be the most profitable over the coming years.
Why Cryoablation is Gaining Huge traction In Cardiac Ablation Technologies Industry?
Rapid Regulatory Approvals Widening Adoption of Cryoablation Procedures
After numerous successful trials of cryoablation, also recognized as cryotherapy, have been done on patients suffering from breast cancer in the US, Japan and European countries. The results have been affirmative. Moreover, the US Food and Drug Administration has already cleared the technique for treating kidney, liver and other cancerous body parts. Lately, Taiwan and Russia have also approved the technique.
Recent advancements in cryotherapy treatment using cold temperatures have made it feasible to treat early-stage cancers but with certain limitations that it can work only on the early-stage breast or cervical cancer. Moreover, this therapy modality cannot be directed to all early cancer patients because of the high possibility of failure if the patient selection is not right.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, technological advancements, mergers, and acquisitions to expand their market ground
- In 2018, the Johnson & Johnson Company announced the launch of the CARTO VIZIGO bi-directional guiding sheath in the U.S. market. This product helps electrophysiologists reduce their dependency on fluoroscopy
- In October 2021, Boston Scientific entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition will expand the Boston Scientific electrophysiology and structural heart product portfolios to include the radiofrequency (RF) NRG® and VersaCross® Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access.
Key Segments Covered in Cardiac Ablation Technologies Industry Report
-
By Technology Type :
- Radiofrequency Cardiac Ablation
- Ultrasound Cardiac Ablation
- Cryoablation Cardiac Ablation
- Microwave Cardiac Ablation
- Laser Cardiac Ablation
- Other Cardiac Ablation Technologies
-
By Application :
- Cardiac Ablation for Atrial Fibrillation
- Cardiac Ablation for Ventricular Tachycardia
- Cardiac Ablation for Other Applications
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 3.1. Global Cardiac Ablation Technologies Market: Market Snapshot 4. Market Overview 4.1. Global Cardiac Ablation Technologies Market: Technology Type Overview 4.2. Global Cardiac Ablation Technologies Market: Key Industry Developments 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Cardiac Ablation Technologies Market Revenue Projections, 2020–2026 4.5. Porter’s Five Forces Analysis 4.6. Global Cardiac Ablation Technologies Market Outlook 5. Market Outlook 5.1. Value Chain Analysis 5.2. Regulatory Scenario 6. Global Cardiac Ablation Technologies Market Analysis, by Technology Type 6.1. Key Findings 6.2. Introduction 6.3. Global Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Technology Type 6.4. Global Cardiac Ablation Technologies Market Value Forecast, by Technology Type 6.4.1. Radiofrequency 6.4.2. Cryoablation 6.4.3. Laser 6.4.4. Ultrasound 6.4.5. Microwave 6.4.6. Other 6.5. Global Cardiac Ablation Technologies Market Analysis, by Technology Type 7. Global Cardiac Ablation Technologies Market Analysis and Forecast, by Application 7.1. Key Findings 7.2. Introduction 7.3. Global Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Application 7.4. Global Cardiac Ablation Technologies Market Value Forecast, by Application 7.4.1. Atrial Fibrillation 7.4.2. Ventricular Tachycardia 7.4.3. Others 7.5. Global Cardiac Ablation Technologies Market Analysis, by Application 8. Global Cardiac Ablation Technologies Market Analysis, by Region 8.1. Global Cardiac Ablation Technologies Market Scenario, by Country 8.2. Global Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Region 8.3. Global Cardiac Ablation Technologies Market Value Forecast, by Region 8.3.1. North America 8.3.2. Europe 8.3.3. Asia Pacific 8.3.4. Latin America 8.3.5. Middle East & Africa 9. North America Cardiac Ablation Technologies Market Analysis 9.1. Key Findings 9.2. North America Cardiac Ablation Technologies Market Overview 9.3. North America Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Country 9.4. North America Cardiac Ablation Technologies Market Forecast, by Country 9.4.1. U.S. 9.4.2. Canada 9.5. North America Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type 9.6. North America Cardiac Ablation Technologies Market Forecast, by Technology Type 9.6.1. Radiofrequency 9.6.2. Cryoablation 9.6.3. Laser 9.6.4. Ultrasound 9.6.5. Microwave 9.6.6. Other 9.7. North America Cardiac Ablation Technologies Market Value Share Analysis, by Application 9.8. North America Cardiac Ablation Technologies Market Forecast, by Application 9.8.1. Atrial Fibrillation 9.8.2. Ventricular Tachycardia 9.8.3. Others 9.9. North America Cardiac Ablation Technologies Market Attractiveness Analysis 10. Europe Cardiac Ablation Technologies Market Analysis 10.1. Key Findings 10.2. Europe Cardiac Ablation Technologies Market Overview 10.3. Europe Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Country/Sub-region 10.4. Europe Cardiac Ablation Technologies Market Forecast, by Country/Sub-region 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Italy 10.4.5. Spain 10.4.6. Rest of Europe 10.5. Europe Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type 10.6. Europe Cardiac Ablation Technologies Market Forecast, by Technology Type 10.6.1. Radiofrequency 10.6.2. Cryoablation 10.6.3. Laser 10.6.4. Ultrasound 10.6.5. Microwave 10.6.6. Other 10.7. Europe Cardiac Ablation Technologies Market Value Share Analysis, by Application 10.8. Europe Cardiac Ablation Technologies Market Forecast, by Application 10.8.1. Atrial Fibrillation 10.8.2. Ventricular Tachycardia 10.8.3. Others 10.9. Europe Cardiac Ablation Technologies Market Attractiveness Analysis 11. Asia Pacific Cardiac Ablation Technologies Market Analysis 11.1. Key Findings 11.2. Asia Pacific Cardiac Ablation Technologies Market Overview 11.3. Asia Pacific Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Country/Sub-region 11.4. Asia Pacific Cardiac Ablation Technologies Market Forecast, by Country/Sub-region 11.4.1. China 11.4.2. India 11.4.3. Japan 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Asia Pacific Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type 11.6. Asia Pacific Cardiac Ablation Technologies Market Forecast, by Technology Type 11.6.1. Radiofrequency 11.6.2. Cryoablation 11.6.3. Laser 11.6.4. Ultrasound 11.6.5. Microwave 11.6.6. Other 11.7. Asia Pacific Cardiac Ablation Technologies Market Value Share Analysis, by Application 11.8. Asia Pacific Cardiac Ablation Technologies Market Forecast, by Application 11.8.1. Atrial Fibrillation 11.8.2. Ventricular Tachycardia 11.8.3. Others 11.9. Asia Pacific Cardiac Ablation Technologies Market Attractiveness Analysis 12. Latin America Cardiac Ablation Technologies Market Analysis 12.1. Key Findings 12.2. Latin America Cardiac Ablation Technologies Market Overview 12.3. Latin America Cardiac Ablation Technologies Market Value Share and Attractiveness Analysis, by Country/Sub-region 12.4. Latin America Cardiac Ablation Technologies Market Forecast, by Country/Sub-region 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Latin America Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type 12.6. Latin America Cardiac Ablation Technologies Market Forecast, by Technology Type 12.6.1. Radiofrequency 12.6.2. Cryoablation 12.6.3. Laser 12.6.4. Ultrasound 12.6.5. Microwave 12.6.6. Other 12.7. Latin America Cardiac Ablation Technologies Market Value Share Analysis, by Application 12.8. Latin America Cardiac Ablation Technologies Market Forecast, by Application 12.8.1. Atrial Fibrillation 12.8.2. Ventricular Tachycardia 12.8.3. Others 12.9. Latin America Cardiac Ablation Technologies Market Attractiveness Analysis 13. Middle East & Africa Cardiac Ablation Technologies Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Cardiac Ablation Technologies Market Overview 13.3. Middle East & Africa Cardiac Ablation Technologies Market Value Share Analysis, by Country/Sub-region 13.4. Middle East & Africa Cardiac Ablation Technologies Market Forecast, by Country/Sub-region 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East and Africa 13.5. Middle East & Africa Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type 13.6. Middle East & Africa Cardiac Ablation Technologies Market Forecast, by Technology Type 13.6.1. Radiofrequency 13.6.2. Cryoablation 13.6.3. Laser 13.6.4. Ultrasound 13.6.5. Microwave 13.6.6. Other 13.7. Middle East & Africa Cardiac Ablation Technologies Market Value Share Analysis, by Application 13.8. Middle East & Africa Cardiac Ablation Technologies Market Forecast, by Application 13.8.1. Atrial Fibrillation 13.8.2. Ventricular Tachycardia 13.8.3. Others 13.9. Middle East & Africa Cardiac Ablation Technologies Market Attractiveness Analysis 14. Competition Landscape 14.1. Cardiac Ablation Technologies Market Share Analysis, by Company, 2017 14.2. Competition Matrix 14.3. Company Profiles 14.3.1. Biosense Webster, Inc. 14.3.1.1. Company Details 14.3.1.2. Business Overview 14.3.1.3. Financial Overview 14.3.1.4. Strategic Overview 14.3.1.5. SWOT Analysis 14.3.2. Medtronic Plc. 14.3.2.1. Company Details 14.3.2.2. Business Overview 14.3.2.3. Financial Overview 14.3.2.4. Strategic Overview 14.3.2.5. SWOT Analysis 14.3.3. Boston Scientific Corporation 14.3.3.1. Company Details 14.3.3.2. Business Overview 14.3.3.3. Financial Overview 14.3.3.4. Strategic Overview 14.3.3.5. SWOT Analysis 14.3.4. Abbott 14.3.4.1. Company Details 14.3.4.2. Business Overview 14.3.4.3. Financial Overview 14.3.4.4. Strategic Overview 14.3.4.5. SWOT Analysis 14.3.5. CardioFocus Inc. 14.3.5.1. Company Details 14.3.5.2. Business Overview 14.3.5.3. Financial Overview 14.3.5.4. Strategic Overview 14.3.5.5. SWOT Analysis 14.3.6. MicroPort Scientific Corporation 14.3.6.1. Company Details 14.3.6.2. Business Overview 14.3.6.3. Financial Overview 14.3.6.4. Strategic Overview 14.3.6.5. SWOT Analysis 14.3.7. Hansen Medical 14.3.7.1. Company Details 14.3.7.2. Business Overview 14.3.7.3. Financial Overview 14.3.7.4. Strategic Overview 14.3.7.5. SWOT Analysis 14.3.8. Stryker Corporation 14.3.8.1. Company Details 14.3.8.2. Business Overview 14.3.8.3. Financial Overview 14.3.8.4. Strategic Overview 14.3.8.5. SWOT Analysis
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Cardiac Ablation Technologies Market Value (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 02: Global Cardiac Ablation Technologies Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 03: Global Cardiac Ablation Technologies Market Value (US$ Mn) Forecast, by Region, 2022-2032
Table 04: North America Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Country, 2022-2032
Table 05: North America Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 06: North America Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Application, 2022-2032
Table 07: Europe Cardiac Ablation Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 08: Europe Cardiac Ablation Technologies Market Value (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 09: Europe Cardiac Ablation Technologies Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 10: Asia Pacific Endoscopic Stricture Management Device Market Size (US$ Mn) Forecast, by Country/Sub-region 2022-2032
Table 11: Asia Pacific Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 12: Asia Pacific Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Application, 2022-2032
Table 13: Latin America Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Country/Region 2022-2032
Table 14: Latin America Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 15: Latin America Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Application, 2022-2032
Table 16: Middle East & Africa Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Country/Region 2022-2032
Table 17: Middle East & Africa Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 18: Middle East & Africa Cardiac Ablation Technologies Market Size (US$ Mn) Forecast, by Application, 2022-2032
Table 19: Biosense Webster, Inc. Product Offerings
Table 20: Boston Scientific Corporation Product Offerings
Table 21: Medtronic Plc. Product Offerings
Table 22: Abbott Product Offerings
Table 23: CardioFocuc Inc. Product Offerings
Table 24: MicroPort Scientific Corporation Product Offerings
Table 25: Hansen Medical Product Offerings
Table 26: Stryker Corporation Product Offerings
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Distribution, by Region, 2022 and 2032
Figure 02: Revenue Share, by Technology Type 2019
Figure 03: Revenue Share, by Application 2019
Figure 04: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Forecast, 2022-2032
Figure 05: Global Cardiac Ablation Technologies Market Value Share, by Technology Type, 2022 and 2032
Figure 06: Global Cardiac Ablation Technologies Market Attractiveness, by Technology Type, 2022-2032
Figure 07: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Radiofrequency, 2022-2032
Figure 08: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Cryoablation, 2022-2032
Figure 09: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Laser, 2022-2032
Figure 10: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Ultrasound, 2022-2032
Figure 11: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Microwave, 2022-2032
Figure 12: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2022-2032
Figure 13: Global Cardiac Ablation Technologies Market Value Share, by Application, 2022 and 2032
Figure 14: Global Cardiac Ablation Technologies Market Attractiveness, by Application, 2022-2032
Figure 15: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Atrial Fibrillation, 2022-2032
Figure 16: Global Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth, by Ventricular Tachycardia, 2022-2032
Figure 17: Global Cardiac Ablation Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022-2032
Figure 19: Global Cardiac Ablation Technologies Market Value Share, by Region, 2022 and 2032
Figure 20: Global Cardiac Ablation Technologies Market Attractiveness, by Region, 2022-2032
Figure 21: North America Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 22: North America Cardiac Ablation Technologies Market Value Share Analysis, by Country, 2022 and 2032
Figure 23: North America Cardiac Ablation Technologies Market Attractiveness Analysis, by Country, 2022-2032
Figure 24: North America Cardiac Ablation Technologies Market Value Share Analysis, by Technologies Type, 2022 and 2032
Figure 25: North America Cardiac Ablation Technologies Market Value Share Analysis, by Application, 2022 and 2032
Figure 26: North America Cardiac Ablation Technologies Market Attractiveness Analysis, by Technologies Type 2022-2032
Figure 27: North America Cardiac Ablation Technologies Market Attractiveness Analysis, by Application, 2022-2032
Figure 28: Europe Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 29: Europe Cardiac Ablation Technologies Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 30: Europe Cardiac Ablation Technologies Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 31: Europe Cardiac Ablation Technologies Market Value Share, by Technology Type, 2022 and 2032
Figure 32: Europe Cardiac Ablation Technologies Market Value Share, by Application, 2022 and 2032
Figure 33: Europe Cardiac Ablation Technologies Market Attractiveness, by Technology Type, 2022-2032
Figure 34: Europe Cardiac Ablation Technologies Market Attractiveness, by Application, 2022-2032
Figure 35: Asia Pacific Cardiac Ablation Technologies Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 36: Asia Pacific Cardiac Ablation Technologies Market Value Share Analysis, by Country, 2022 and 2032
Figure 37: Asia Pacific Cardiac Ablation Technologies Market Attractiveness Analysis, by Country, 2022-2032
Figure 38: Asia Pacific Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type, 2022 and 2032
Figure 39: Asia Pacific Cardiac Ablation Technologies Market Value Share Analysis, by Application, 2022 and 2032
Figure 40: Asia Pacific Cardiac Ablation Technologies Market Attractiveness Analysis, by Technology Type 2022-2032
Figure 41: Asia Pacific Cardiac Ablation Technologies Market Attractiveness Analysis, by Application, 2022-2032
Figure 42: Latin America Cardiac Ablation Technologies Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 43: Latin America Cardiac Ablation Technologies Market Value Share Analysis, by Country, 2022 and 2032
Figure 44: Latin America Cardiac Ablation Technologies Market Attractiveness Analysis, by Country, 2022-2032
Figure 45: Latin America Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type, 2022 and 2032
Figure 46: Latin America Cardiac Ablation Technologies Market Value Share Analysis, by Application, 2022 and 2032
Figure 47: Latin America Cardiac Ablation Technologies Market Attractiveness Analysis, by Technology Type 2022-2032
Figure 48: Latin America Cardiac Ablation Technologies Market Attractiveness Analysis, by Application, 2022-2032
Figure 49: Middle East & Africa Cardiac Ablation Technologies Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 50: Middle East & Africa Cardiac Ablation Technologies Market Value Share Analysis, by Country, 2022 and 2032
Figure 51: Middle East & Africa Cardiac Ablation Technologies Market Attractiveness Analysis, by Country, 2022-2032
Figure 52: Middle East & Africa Cardiac Ablation Technologies Market Value Share Analysis, by Technology Type, 2022 and 2032
Figure 53: Middle East & Africa Cardiac Ablation Technologies Market Value Share Analysis, by Application, 2022 and 2032
Figure 54: Middle East & Africa Cardiac Ablation Technologies Market Attractiveness Analysis, by Technology Type 2022-2032
Figure 55: Middle East & Africa Cardiac Ablation Technologies Market Attractiveness Analysis, by Application, 2022-2032
Figure 56: Global Cardiac Ablation Technologies Market Share Analysis, by Company, 2017 (Estimated)
Figure 57: Biosense Webster, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 58: Biosense Webster, Inc. Breakdown of Net Sales, by Business Segment, 2021
Figure 59 Biosense Webster, Inc. Breakdown of Net Sales, by Region, 2021
Figure 60: Boston Scientific Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 61: Boston Scientific Corporation Breakdown of Net Sales, by Region, 2017
Figure 62: Boston Scientific Corporation Breakdown of Net Sales, by Business Segment, 2021
Figure 63: Medtronic Plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 64: Medtronic Plc. Breakdown of Net Sales, by Business Segment, 2021
Figure 65: Medtronic Plc. Breakdown of Net Sales, by Region, 2021
Figure 66: Abbott Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 67: Abbott R&D Spending (%) of Total Revenue 2020–2021
Figure 68: Abbott Breakdown of Net Sales, by Region, 2021
Figure 69: Abbott Breakdown of Net Sales, by Business Segment, 2021
Figure 70: MicroPort Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 71: MicroPort Scientific Corporation R&D Spending on Total Revenue (%), 2016–2017
Figure 72: MicroPort Scientific Corporation Breakdown of Net Sales, by Region, 2017
Figure 73: MicroPort Scientific Corporation Breakdown of Net Sales, by Business Segment, 2021
Figure 74: Stryker Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 75: Stryker Corporation R&D Spending on Total Revenue (%), 2020–2021
Figure 76: Stryker Corporation Breakdown of Net Sales, by Region, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the cardiac ablation technologies worth?
As of 2022, cardiac ablation technologies demand is likely to reach US$ 4,919.35 Mn
What was the last 5 years CAGR for the cardiac ablation technologies market?
From 2017 to 2021, cardiac ablation technologies uptake expanded at 11.1% CAGR.
What are the future growth projections for cardiac ablation technologies demand?
According to fact.MR, the cardiac ablation technologies industry is projected to grow at a CAGR of 11.8% to surpass US$ 15 Bn by 2032.
What is the growth outlook for the Asia-Pacific cardiac ablation technologies industry?
The market for cardiac ablation technologies is likely to generate 40% of the revenue across Asia-Pacific
Which are key manufacturers currently operate in the cardiac ablation technologies domain?
Boston Scientific Corporation, Biosense Webster Inc., Johnson & Johnson, Medtronic Plc. and CardioFocus Inc., St. Jude Medical, Inc. (Abbott) are some prominent cardiac ablation technology giants
Which is the fastest-growing segment in cardiac ablation technologies?
The radiofrequency segment of is the fastest-growing segment in the market, likely to account for 50% of total revenue
Cardiac Ablation Technologies Market